Cite

HARVARD Citation

    Cheng, Y. et al. (2020). In situ immunization of a TLR9 agonist virus-like particle enhances anti-PD1 therapy. Journal for immunotherapy of cancer. 8 (2), p. . [Online]. 
  
Back to record